Prakt. lékáren. 2021; 17(4): 220-225 | DOI: 10.36290/lek.2021.048

Possibilities of influencing acute cough of respiratory infections in children

Hana Kotolová
Ústav farmakologie a toxikologie, Farmaceutická fakulta, Masarykova univerzita, Brno

Respiratory infections are one of the most common infectious diseases affecting both children and adults. Cough, as a symptom of a cold illness, can go through a phase of dry cough which alternates with a phase of productive cough. In children, it is advisable to avoid centrally acting antitussives. The use of levodropropizine seems to be the most suitable of peripheral antitussives. For productive cough there is a long-term discussion and reassessment of the benefits of mucomodulatory drugs. According to recommendations, erdostein is recommended. From traditional medicine it is recommended even by leading experts to use honey and preparations based on honey syrups to influence the frequency and intensity of cough in children.

Keywords: acute respiratory infections, antitussives, mucoactive substances, natural products, honey, honey syrup.

Published: December 14, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotolová H. Possibilities of influencing acute cough of respiratory infections in children. Praktické lékárenství. 2021;17(4):220-225. doi: 10.36290/lek.2021.048.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Juřica J. Moderní terapie kašle. Prakt. lékáren. 2013; 9(6): 219-223.
    2. Švarc M. Některé aspekty diagnostiky a terapie kašle zejména v těhotenství a u dětí. Med. praxi 2017; 14(1): 16-20 Go to original source...
    3. Fojtů H. Kašel - diferenciální diagnostika a terapie. Remedia 2013; 23(3): 180-185.
    4. Kotolová H. Symptomatická léčba chřipky a nachlazení, Doporučený postup, Česká lékárnická komora, verze RR 2018.
    5. Juřica J. Farmakoterapie kašle ve zkratce. Prakt. Lékáren. 2017; 13(1): 306-311. Go to original source...
    6. Kotolová H. Symptomatická léčba chřipky a nachlazení.Prakt. Lékáren. 2017; 13(1): 22-29. Go to original source...
    7. Smith SM, et al. Over‑the‑counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No.: CD001831. Go to original source...
    8. Kodein - omezení používání pro léčbu kašle a nachlazení u dětí, SÚKL, farmakovigilační informace, 9. 6. 2015.
    9. Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith, JA, Canning BJ, Page CP. Antitussive Drugs-Past, Present, and Future. Pharmacological Reviews, 2014; 66(2): 468. Go to original source... Go to PubMed...
    10. Zanasi A, Lanata L, Fontana G, Saibene F, Dicpinigaitis P, De Blasio F. Levodropropizine for treating cough in adult and children: a meta‑analysis of published studies. Multidisciplinary Respiratory Medicine. 2015; 10(1): 19. Go to original source... Go to PubMed...
    11. MV‑AISLP pro Windovs, verze 1.2020
    12. Malesker MA, Callahan‑Lyon P, Ireland B, Irwin RS; CHEST Expert Cough Panel. Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. Chest. 2017; 152(5): 1021-1037. Go to original source... Go to PubMed...
    13. Vančíková Z. Kašel u dětí a možnosti jeho léčby. Pediatr. praxi 2015; 16(6): 395-400.
    14. European Medicines Agency (EMA). Revised assessment report - procedure under article 31 of directive 2001/83/EC resulting from pharmacovigilance data. Ambroxol and bromhexine containing medicinal products. https://www.ema.europa.eu/documents/referral/ambroxol‑bromhexine‑article-31-referral‑prac‑assessment‑report_en.pdf.EMA/PRAC/800767/2015. Published September 10, 2015.
    15. Mallet P, Mourdi N, Dubus JC, et al. Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey. PLoS One. 2011; 6(7): e22792. Go to original source... Go to PubMed...
    16. Scaglione F, Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?. Clin Med Insights Ear Nose Throat. 2019; 12: 1179550618821930. Published 2019 Jan 9. doi:10.1177/1179550618821930 Go to original source... Go to PubMed...
    17. https://ospdl.webflow.io/posts/stanovisko‑ospdl‑cls‑jep‑k-revizi‑registrace‑leku‑s-mukolytickym‑ucinkem (cit. 20. 8. 2020).
    18. http://www.sukl.cz/modules/medication/search.php SPC přípravku Erdostein (cit. 20. 8. 2020).
    19. Braga PC, Dal Sasso M, Sala MT, Gianelle V. Effects of Erdosteine and Its Metabolites on Bacterial Adhesiveness, Arzneim.-Forsch./Drug Res. 49 (I), Nr, 4 (1999).
    20. Braga PC, et al. Bacterial adhesiveness: Effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone. Chemotherapy 2001; 47: 208-214. Go to original source... Go to PubMed...
    21. Balli F, et al. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. International Journal of Clinical Pharmacology and Therapeutics 2001; 1: 16-22. Go to original source... Go to PubMed...
    22. Miyake K, Kaise T, Hosoe H, et al. The effect of erdosteine and its active metabolite on reactive oxygen species production by inflammatory cells. Inflamm Res 1999; 48: 205-209. Go to original source... Go to PubMed...
    23. Šmejkal K. Use of plant extracts as an efficient alternative therapy of respiratory tract infections. Čes. Slov. Farm. 2016; 65: 139-160.
    24. Šmejkal K. 2019. Propolis jako protizánětlivý a antibakteriální prostředek. Prakt. lékáren. 2019; 15(2): 85-89. Go to original source...
    25. Meo SA, Al‑Asiri SA, Mahesar AL, Ansari MJ. Role of honey in modern medicine. Saudi J Biol Sci. 2017; 24(5): 975-978. Go to original source... Go to PubMed...
    26. Erejuwa OO, Sulaiman SA, Ab Wahab MS. Honey: A Novel Antioxidant. Molecules. 2012 Apr 12; 17(4): 4400-4423. Go to original source... Go to PubMed...
    27. Kwakman PH, te Velde AA et al. How honey kills bacteria. FASEB J. 2010 Jul; 24(7): 2576-2582 Go to original source... Go to PubMed...
    28. Paul IM, Beiler J, et al. Effect of Honey, Dextromethorphan, and No Treatment on Nocturnal Cough and Sleep Quality for Coughing Children and Their Parents. Arch Pediatr Adolesc Med. 2007 Dec; 161(12): 1140-1146. Go to original source... Go to PubMed...
    29. Shadkam MN, Mozaffari‑Khosravi H, et al. A Comparison of the Effect of Honey, Dextromethorphan, and Diphenhydramine on Nightly Cough and Sleep Quality in Children and Their Parents. J Altern Complement Med. 2010 Jul; 16(7): 787-793. Go to original source... Go to PubMed...
    30. Cohen HA, Rozen J, et al. Effect of Honey on Nocturnal Cough and Sleep Quality: A Double‑blind, Randomized, Placebo‑Controlled Study. Pediatrics. 2012 Sep; 130(3): 465-471. Go to original source... Go to PubMed...
    31. Miceli Sopo S, Greco M, Monaco S, et al. Effect of multiple honey doses on non‑specific acute cough in children. An open randomised study and literature review. Allergol Immunopathol (Madr). 2015; 43(5): 449-455. Go to original source... Go to PubMed...
    32. Cohen HA, Hoshen M, Gur S, Bahir A, Laks Y, Blau H. Efficacy and tolerability of a polysaccharide‑resin‑honey based cough syrup as compared to carbocysteine syrup for children with colds: a randomized, single‑blinded, multicenter study. World J Pediatr. 2017; 13(1): 27-33. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.